Tower Research Capital LLC (Trc) Ardelyx, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ardelyx, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,408 shares of ARDX stock, worth $17,551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,408
Previous 27,345
87.54%
Holding current value
$17,551
Previous $202,000
88.61%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ARDX
# of Institutions
219Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$111 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$90.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$70 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$62.5 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$46.1 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $796M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...